Grail (GRAL) Total Non-Current Liabilities (2023 - 2026)
Grail's (GRAL) quarterly Total Non-Current Liabilities came in at $299.8 million in Q1 2026, down 30.52% YoY from $431.5 million in Q1 2025, and down 12.18% on a QoQ basis from $341.4 million in Q4 2025.
Grail (GRAL) Total Non-Current Liabilities (2023 - 2026) Analysis & Trends
Grail (GRAL) has 4 years of Total Non-Current Liabilities data on file, last reported at $299.8 million in Q1 2026.
- Quarterly Total Non-Current Liabilities fell 30.52% year-over-year to $299.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $299.8 million (down 30.52% YoY) and the FY2025 annual result came in at $341.4 million, down 28.53% from the prior year.
- Total Non-Current Liabilities declined to $299.8 million in Q1 2026, from $341.4 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $572.5 million in Q2 2024 to a low of $266.1 million in Q4 2023.
- A 4-year average of $406.7 million and a median of $385.3 million in 2025 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2024 — Total Non-Current Liabilities jumped 79.49% — and 2025, when it plunged 32.7%.
- Tracing GRAL's Total Non-Current Liabilities over 4 years: stood at $266.1 million in 2023, then jumped by 79.49% to $477.7 million in 2024, then fell by 28.53% to $341.4 million in 2025, then fell by 12.18% to $299.8 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $299.8 million (Q1 2026), $341.4 million (Q4 2025), and $358.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 108.64 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 85.84 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 715.49 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 5.45 Bn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 22.94 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 542.10 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 6.36 Bn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 3.39 Bn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 9.19 Bn |
| 10 | Grail | 3.56 Bn | 2.70 Bn | 21.34 Mn | 297.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 297.86 Mn |
| Mar 31, 2026 | 299.84 Mn |
| Dec 31, 2025 | 341.40 Mn |
| Sep 30, 2025 | 358.27 Mn |
| Jun 30, 2025 | 385.29 Mn |
| Mar 31, 2025 | 431.51 Mn |
| Dec 31, 2024 | 477.67 Mn |
| Sep 30, 2024 | 528.06 Mn |
| Jun 30, 2024 | 572.51 Mn |
| Dec 31, 2023 | 266.13 Mn |